Acasă

Leveraging CGP and ctDNA for improved cancer outcomes

DNA

Tohoku University Jan 16 2025 Researchers from Iwate Medical University and Tohoku University have revealed that it is possible to predict cancer relapse and treatment response by measuring circulating tumor DNA (ctDNA), in tandem with data from comprehensive genomic profiling (CGP). CGP test results can be used to tailor recommendations for advanced cancer treatment, with the goal of matching individual patients with the most effective option to prolong survival. This study retrospectively

Tag-uri: DNA

Leveraging CGP and ctDNA for improved cancer outcomes https://www.news-medical.net - 16.01.2025 08:58

din zilele anterioare

Leveraging CGP and ctDNA for improved cancer outcomes https://www.news-medical.net - 16.01.2025 08:58
STIRILE OREI
IN FOCUS: ‘When I die, who’s going to look after you?’ – the pains of caring for adults with disabilities https://www.channelnewsasia.com/ - 06:00
IN FOCUS: ‘When I die, who’s going to look after you?’ – the pains of caring for adults with disabilities https://www.channelnewsasia.com - 06:00
IN FOCUS: ‘I only wish to live one second longer’ – the pains of parents of adults with disabilities https://www.channelnewsasia.com/ - 06:00
IN FOCUS: ‘I only wish to live one second longer’ – the pains of parents of adults with disabilities https://www.channelnewsasia.com - 06:00
Trump’s Talk of the Panama Canal Taps Into Old Myths About U.S. Power http://time.com - 16:31
© Copyright 2017 Mediafax SA | Termeni și condiţii | About cookies | Confidentialitate

monitoruldestiri@mediafax.ro

Fotografiile folosite de monitoruldestiri.ro sunt proprietatea Mediafax. Este interzisă republicarea acestora în lipsa unui acord din partea Mediafax. Pentru a obține acest acord, vă rugăm să ne contactați.